Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vγ9Vδ2 T cells in chronically infected patients undergoing structured treatment interruption

Journal of Infectious Diseases

Volumn 186, Issue 6, 2002, Pages 847-850

  Martini, Federico ^b   Poccia, Fabrizio ^b   Goletti, Delia ^b   Carrara, Stefania ^b   Vincenti, Donatella ^b   D'Offizi, Gianpiero ^b   Agrati, Chiara ^b   Ippolito, Giuseppe ^b   Colizzi, Vittorio ^a   Pucillo, Leopoldo Paolo ^b   Montesano, Carla ^b  

^a Intl Ctr AIDS/Emerging Infections   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CLINICAL ARTICLE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SIDE EFFECT; T LYMPHOCYTE; VIREMIA; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HIV; HIV INFECTIONS; HUMANS; KINETICS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA, VIRAL; T-LYMPHOCYTES; VIRAL LOAD; VIRUS REPLICATION;

EID: 0037105711     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/342410     Document Type: Article

References (15)

1. Innate T-cell immunity to nonpeptidic antigens
2. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire
3. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes
4. Phosphoantigen-reactive Vγ9Vδ2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines
5. Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections
6. γδ T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy
7. Control of HIV despite the discontinuation of antiretroviral therapy
8. Is interruption of HIV therapy always harmful?
9. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
10. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells
11. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
12. Functional inactivation in the whole population of human V gamma 9/V delta 2 T lymphocytes induced by a nonpeptidic antagonist
13. + T cells
14. Interruption/stopping antiretroviral therapy and the risk of clinical disease: Results from the EuroSIDA study